A Study to Assess NEU-627 in Healthy Participants
NCT06900751
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
NEU-627
OTHER:
Placebo
Sponsor
Neuron23 Inc.